Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth
Edelweiss Asset Management Limited · Direct Plan · Growth
Fund overview
Nil
Returns & rankings
| Period | Fund Returns | Category Avg. | Rank | VS Category |
|---|---|---|---|---|
| … | ||||
Green = fund outperformed the category average for that period; red = underperformed. Periods under 1 year always show absolute (non-annualised) returns. Past performance does not guarantee future returns.
Return calculator
One-time investment
₹1,000
| Over the past | Total investment | Would've become | Returns |
|---|---|---|---|
| 1 Year | ₹1,000 | ₹1,156 | +156 |
| 3 Years | ₹1,000 | ₹1,543 | +543 |
| 5 Years | ₹1,000 | ₹2,061 | +1,061 |
Calculated using the fund's annualised return since inception (15.6% p.a.) as period-wise historical returns aren't available in the current feed. Actual returns fluctuate and are not guaranteed. Mutual fund investments are subject to market risks.
Holdings
45 securitiesTop 10 holdings make up 51.0% of the portfolio.
| Security | Sector | Market Cap | Weight |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Pharmaceuticals & Biotechnology | Large Cap | 10.45% |
| Divi'S Laboratories Ltd | Pharmaceuticals & Biotechnology | Large Cap | 7.09% |
| Eli Lilly & Co | Pharmaceuticals & Biotechnology | Overseas Equity | 6.46% |
| Apollo Hospitals Enterprises Ltd | Healthcare Services | Large Cap | 5.25% |
| Johnson & Johnson | Pharmaceuticals & Biotechnology | Overseas Equity | 4.45% |
| Laurus Labs Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 4.44% |
| Torrent Pharmaceuticals Ltd | Pharmaceuticals & Biotechnology | Large Cap | 4.38% |
| Cipla Ltd | Pharmaceuticals & Biotechnology | Large Cap | 4.34% |
| Max Healthcare Institute Ltd | Healthcare Services | Mid Cap | 4.19% |
| Dr. Reddys Laboratories Ltd | Pharmaceuticals & Biotechnology | Mid Cap | 3.95% |
Portfolio Allocation
Equity / Debt / Cash
Total Value
₹192 Cr
Market Cap Split
Total Value
100%
Equity sector allocation
Total Value
₹192 Cr
Exit load, stamp duty & tax
26-Oct-20
Nil
0.005% (from July 1st, 2020)
Taxation depends on the fund category and holding period. Consult the scheme document or a tax advisor for details.
Risk & Performance Ratios (1Y)
| Standard Deviation | 14.35% |
| Beta | 0.87 |
| Sharpe Ratio | 2.10 |
| Sortino Ratio | 0.75 |
| Treynor Ratio | 0.34 |
| Jensen's Alpha | 21.77 |
| Information Ratio | 0.60 |
| R-Squared | 64.47% |
| Max Drawdown | -4.57% |
| Upside Capture | 148.74% |
| Downside Capture | 46.97% |
Fund management
Scheme Details
Investment objective
The Investment Objective Of The Scheme Is To Adopt Passive Investment Strategy. The Fund Will Invest In Stocks Comprising In The Msci India Domestic & World Healthcare 45 Index With The Objective To Provide Investment Returns That, Before Expenses, Closely Corresponds To The Returns Equivalent To The Index, Subject To Tracking Errors.
Fund house
Edelweiss Asset Management Limited
Frequently asked questions
What is the NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The NAV of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth is ₹23.78 as of 19 Oct 2026. NAV is updated at the end of every trading day.
How much expense ratio is charged by Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The expense ratio charged by Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth is 0.55%.
What is the Min. SIP of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The minimum SIP investment in Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth is ₹100 per month.
What is the Min. Lumpsum of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
The minimum lumpsum investment in Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth is ₹100.
What is the Exit Load of Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth?
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Plan - Growth does not charge an exit load.
.svg){kind=small}